(0.27%) 5 475.09 points
(0.13%) 39 170 points
(0.83%) 17 879 points
(0.10%) $83.46
(-0.04%) $2.48
(0.18%) $2 343.00
(0.51%) $29.77
(0.54%) $994.00
(0.04%) $0.931
(0.14%) $10.66
(0.01%) $0.791
(-0.01%) $86.75
@ $76.41
Issued: 1 Jul 2024 @ 15:22
Return: -0.20%
Previous signal: Jun 28 - 15:50
Previous signal:
Return: -1.96 %
Live Chart Being Loaded With Signals
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally...
Stats | |
---|---|
Today's Volume | 3.02M |
Average Volume | 2.80M |
Market Cap | 34.81B |
EPS | $0.820 ( Q1 | 2024-04-30 ) |
Next earnings date | ( $0.970 ) 2024-07-23 |
Last Dividend | $0.0300 ( 2024-04-18 ) |
Next Dividend | $0 ( N/A ) |
P/E |
22.17 (Sector) 42.63 (Industry) 31.08 |
ATR14 | $2.08 (2.72%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-07-01 | Rackliffe Philip | Sell | 0 | Common Stock, par value $0.01 per share |
2024-07-01 | Rackliffe Philip | Sell | 7 838 | Employee Stock Option (right to buy) |
2024-07-01 | Rackliffe Philip | Sell | 4 631 | Employee Stock Option (right to buy) |
2024-07-01 | Rackliffe Philip | Sell | 3 834 | Employee Stock Option (right to buy) |
2024-06-24 | Holton Adam Y | Buy | 0 |
INSIDER POWER |
---|
-97.71 |
Last 99 transactions |
Buy: 601 714 | Sell: 58 058 262 |
Volume Correlation
GE HealthCare Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
GE HealthCare Correlation - Currency/Commodity
GE HealthCare Financials
Annual | 2023 |
Revenue: | $19.55B |
Gross Profit: | $7.92B (40.52 %) |
EPS: | $3.04 |
FY | 2023 |
Revenue: | $19.55B |
Gross Profit: | $7.92B (40.52 %) |
EPS: | $3.04 |
FY | 2022 |
Revenue: | $18.34B |
Gross Profit: | $7.18B (39.14 %) |
EPS: | $4.22 |
FY | 2021 |
Revenue: | $17.59B |
Gross Profit: | $7.17B (40.80 %) |
EPS: | $4.94 |
Financial Reports:
No articles found.
GE HealthCare Dividends
(Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.0300 (N/A) |
$0.0300 (N/A) |
$0.0300 (N/A) |
$0.0300 (N/A) |
$0.0300 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0300 | 2023-05-22 |
Last Dividend | $0.0300 | 2024-04-18 |
Next Dividend | $0 | N/A |
Payout Date | 2024-05-15 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | $0.150 | -- |
Avg. Dividend % Per Year | 0.11% | -- |
Score | 4.59 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.69 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|---|---|
2023 | $0.0900 | 0.16% |
2024 | $0.0600 | 0.08% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
18 Apr 2024 | $0.0300 | 22 Mar 2024 | 19 Apr 2024 | 15 May 2024 |
12 Jan 2024 | $0.0300 | 08 Dec 2023 | 16 Jan 2024 | 15 Feb 2024 |
19 Oct 2023 | $0.0300 | 22 Sep 2023 | 20 Oct 2023 | 15 Nov 2023 |
20 Jul 2023 | $0.0300 | 23 Jun 2023 | 21 Jul 2023 | 15 Aug 2023 |
22 May 2023 | $0.0300 | 25 Apr 2023 | 23 May 2023 | 15 Jun 2023 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0805 | 1.500 | 8.39 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0487 | 1.200 | 8.38 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.218 | 1.500 | 8.69 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0350 | -1.000 | 9.65 | -9.65 | [0 - 1] |
currentRatioTTM | 1.058 | 0.800 | 9.71 | 7.77 | [1 - 3] |
quickRatioTTM | 0.741 | 0.800 | -0.345 | -0.276 | [0.8 - 2.5] |
cashRatioTTM | 0.288 | 1.500 | 9.51 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.300 | -1.500 | 5.00 | -7.50 | [0 - 0.6] |
interestCoverageTTM | 4.44 | 1.000 | 9.47 | 9.47 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.50 | 2.00 | 8.50 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.65 | 2.00 | 8.18 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.305 | -1.500 | 4.78 | -7.17 | [0 - 2.5] |
grossProfitMarginTTM | 0.407 | 1.000 | 6.55 | 6.55 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.124 | 1.000 | 9.52 | 9.52 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.212 | 1.000 | 9.93 | 9.93 | [0.2 - 2] |
assetTurnoverTTM | 0.605 | 0.800 | 9.30 | 7.44 | [0.5 - 2] |
Total Score | 13.07 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 22.63 | 1.000 | 7.82 | 0 | [1 - 100] |
returnOnEquityTTM | 0.218 | 2.50 | 9.16 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.65 | 2.00 | 8.78 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.154 | 1.500 | 6.15 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.50 | 2.00 | 8.50 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0350 | 1.500 | 9.65 | -9.65 | [0 - 1] |
pegRatioTTM | 9.06 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.105 | 1.000 | 9.87 | 0 | [0.1 - 0.5] |
Total Score | 7.69 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
GE HealthCare
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women\'s health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women\'s health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators